Viewing nowLipican Tablet 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

MFDS item code 200703050 · Notified 2007.03.09 · Insurance code 653801380
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medicine helps to reduce the risk of cardiovascular diseases. In particular, it reduces the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease and patients with type 2 diabetes. Additionally, patients with coronary heart disease can lower the risk of non-fatal myocardial infarction and stroke, vascular surgery, congestive heart failure hospitalization, and angina. It is also used in the treatment of hyperlipidemia, lowering bad cholesterol levels and raising good cholesterol levels in patients with hypercholesterolemia and dyslipidemia. This drug is used adjunctively in the treatment of certain types of dyslipidemia that are difficult to manage through diet, and it is also applicable in the treatment of familial hypercholesterolemia in children. Overall, it is used to improve heart health and effectively reduce the risk of diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are generally similar to those in the general adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg per day (there are no clinical data on administering doses of this medicine higher than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause unusual symptoms in muscles; therefore, if muscle pain or weakness worsens or if there is a significant increase in creatine kinase levels, discontinue use immediately and consult a doctor. This medicine may affect liver function, so patients with liver disease or elevated liver enzyme levels should not use it and should undergo regular liver function tests during treatment. Women who are pregnant or may become pregnant and nursing mothers should not take this medication. Women of childbearing age should use appropriate contraceptive methods while taking this medication. This medication should not be given to children, especially those under 10 years of age, and the long-term safety in adolescents under 18 has not been adequately studied. Patients with reduced kidney function or a history of muscle diseases should be carefully monitored while taking this medication due to an increased risk of myopathy or rhabdomyolysis. There are many interactions with other medications, such as certain antibiotics, antifungals, antivirals, immunosuppressants, and grapefruit juice, which may increase blood concentrations and the risk of side effects; therefore, it is essential to inform your doctor or pharmacist. This medicine contains lactose, so patients with lactose intolerance should avoid taking it. If abnormal symptoms such as muscle pain, weakness, fever, nausea, vomiting, jaundice, skin rash occur during treatment, notify medical personnel immediately and seek treatment. In case of overdose, there is no specific antidote, so appropriate treatment should be given according to the symptoms, and blood tests should be conducted to check liver function and muscle damage. Keep out of the reach of children, and store in the original container to prevent misuse or degradation of quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees at room temperature.
White oval film-coated tablet
30 tablets/bottle, 120 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.